Ambit Biosciences , a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced fourth quarter and full-year operating results for 2013.
http://ift.tt/1eWYeEK
http://ift.tt/1eWYeEK
No comments:
Post a Comment